AVI BioPharma Inc. (AVII) Key Ratios

Profile for AVI BioPharma Inc.  (AVII) 
$ 1.11 R     -0.09 (-7.50%) Volume: 1.18 m 4:00 PM EST Feb 10, 2012
After Hours:  $ 1.08   -0.03 (-2.70%) Volume: 900  4:00 PM EST Feb 10, 2012
Income Statements
Revenue (LTM) ($): 48.92 m
Revenue per Share (LTM) ($): 0.36
Revenue per Employee (LTM) ($): 499,204.09
Revenue Growth 3 Yr: 27.41%
Revenue Growth 5 Yr: 147.18%
 
Dividends & Splits
Annual Dividend Rate ($): N/A
Annual Dividend Yield: N/A
Dividend Growth 3 Yr: N/A
Dividend Growth 5 Yr: N/A
Ex-Dividend Date: N/A
Payment Type: N/A
Financial Strength (LTM)
Quick Ratio: 1.90
Current Ratio: 2.00
Long Term Debt to Total Capital: 0.05
Total Debt to Equity: 0.06
Interest Coverage: N/A
Leverage Ratio: 1.90
 
Profitability (LTM)
Gross Margin: N/A
EBIT Margin: -17.50%
EBITDA Margin: -56.20%
Pre-Tax Profit Margin: N/A
Profit Margin (Cont. Op): -17.50%
Profit Margin (Total Op): -17.50%
Management Effectiveness LTM 5 Yr Avg
Return on Equity N/A N/A
Return on Capital -128.60% -128.60%
Return on Assets -66.10% -66.10%
 
Assets
Asset Turnover: 0.90
Inventory Turnover: N/A
Receivable Turnover: 10.30
Valuation Measures
P/E Ratio: N/A
P/E High - Last 5 Years: N/A
P/E Avg. High - Last 5 Years: N/A
P/E Low - Last 5 Years: N/A
P/E Avg. Low - Last 5 Years: N/A
 
Price to Sales: 3.33
Price to Book: 4.75
Price to Tangible Book: 5.57
Price to Cash Flow: -20.40
Price to Free Cash: -6.90